STAR Compounds Show Potential to Treat GBA1-linked Parkinson’s
Gain Therapeutics announced that preclinical studies with two of its compounds, GT-02287 and GT-02329, showed they could reduce the…
Articles by Yedida Y Bogachkov PhD
2 Northwestern Researchers Awarded $17.9M in ASAP Grants
Scientists from Northwestern University will use two grants — totaling $17.9 million — from the Aligning Science Across Parkinson’s…
$1.1M NIH Grant Will Further AI-powered Research Analysis
A team of scientists from the University of Florida (UF) will use a $1.1 million grant to further their work…
FDA Approval Sought to Begin Phase 2 Trial of KM-819
Fascinate Therapeutics has submitted an investigational new drug (IND) application to the U.S. Food and Drug Administration (FDA) to initiate…
Mutation Affecting Myelin Protein May Raise Parkinson’s Risk
A specific genetic variant, or mutation, that is associated with an increased risk of developing amyotrophic lateral sclerosis (ALS) may also raise…
JUBIwatch Device Targets Medication Adherence
Jubilee BioTech has developed JUBIwatch, a new device intended to improve patients’ medication adherence — taking medicines at the right…
Caltech Team to Use $11M ASAP Grant to Study Gut-brain Connection
A team of researchers at Caltech will be looking into the interactions between the brain and the gut in…
FDA OKs Phase 2 Trial of Oral NE3107 in Easing Inflammation
The launch of a Phase 2 trial into the safety and early efficacy of oral NE3107 in treating Parkinson’s disease patients…
$8.9M Grant Will Drive Research Into Gut-to-brain Protein Spread
A neurological surgery professor from Weill Cornell Medicine and his team will use a three-year, $8.9 million research grant to…
Altoida Partners to Test Precision Device in Detecting Parkinson’s
Altoida announced a three-year collaboration with a Greek university to investigate whether the company’s precision neurology medical device can…